QA: GLYCOMIMETICS INC in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001253689_2021_GLYCOMIMETICS_INC.pdf

Logs

info NetIncome node detected by revenue/expenses heuristic input.sec.calculation_linkbase.edgar_model_mapping {'net_inc_node': 'OperatingIncomeLoss'}

Graph

Absolute values for 0001253689, GLYCOMIMETICS INC

  xvar xval
0 AssetsCurrent 138,273,345
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 620,673
3 remainder_Assets 3,938,151
4 LiabilitiesCurrent 12,428,369
5 LiabilitiesNoncurrent 1,920,015
6 remainder_Liabilities 264,329
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 16,743,127
9 ResearchAndDevelopmentExpense 44,929,198
10 remainder_Expenses 0
11 remainder_Revenues 10,162,935
12 remainder_NetIncome 0
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 142,832,169
1 Liabilities 14,612,713
2 Expenses 61,672,325
3 Revenues 10,162,935
4 StockholdersEquity 128,219,456
5 NetIncome -51,509,390
6 ComprehensiveNetIncome -51,509,390
7 BaseVar 114,640,071
8 EconomicCapitalRatio 2.15

Edgar->Model Mapping

Feature Distribution

Change over Time